Mainz Biomed Company Insiders
| MYNZ Stock | USD 6.23 0.89 16.67% |
Mainz Biomed employs about 65 people. The company is managed by 12 executives with a total tenure of roughly 152 years, averaging almost 12.0 years of service per executive, having 5.42 employees per reported executive. Break down of Mainz Biomed's management performance can provide insight into the company performance.
Mainz |
Mainz Biomed Management Team Effectiveness
The company has return on total asset (ROA) of (0.9924) % which means that it has lost $0.9924 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (43.3371) %, meaning that it created substantial loss on money invested by shareholders. Mainz Biomed's management efficiency ratios could be used to measure how well Mainz Biomed manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.64 in 2025. Return On Capital Employed is likely to rise to -4.72 in 2025. At this time, Mainz Biomed's Non Current Assets Total are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 7.7 M in 2025, whereas Total Assets are likely to drop slightly above 10.4 M in 2025.Common Stock Shares Outstanding is likely to drop to about 12.1 M in 2025. Net Loss is likely to rise to about (10 M) in 2025
Mainz Biomed Workforce Comparison
Mainz Biomed BV is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 8,672. Mainz Biomed maintains roughly 65.0 in number of employees contributing less than 1% to equities under Health Care industry.
Mainz Biomed BV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Mainz Biomed BV Price Series Summation is a cross summation of Mainz Biomed price series and its benchmark/peer.
Mainz Biomed Notable Stakeholders
A Mainz Biomed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mainz Biomed often face trade-offs trying to please all of them. Mainz Biomed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mainz Biomed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Corinna Gorges | Head RD | Profile | |
| Chris PMP | Chief Officer | Profile | |
| Frank KriegSchneider | Chief Officer | Profile | |
| Darin Leigh | Chief Officer | Profile | |
| Philipp Freese | Chief Officer | Profile | |
| Petra Ploesser | Head Quality | Profile | |
| Guido Baechler | CEO Director | Profile | |
| William Caragol | Chief Officer | Profile | |
| Stefan Erlach | Head Resources | Profile | |
| Christopher PMP | Chief Officer | Profile | |
| William CPA | Chief Officer | Profile | |
| Moritz Eidens | Chief Director | Profile |
About Mainz Biomed Management Performance
The success or failure of an entity such as Mainz Biomed BV often depends on how effective the management is. Mainz Biomed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mainz management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mainz management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.52) | (2.64) | |
| Return On Capital Employed | (4.96) | (4.72) | |
| Return On Assets | (1.96) | (2.06) | |
| Return On Equity | (9.31) | (8.84) |
Please note, the imprecision that can be found in Mainz Biomed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mainz Biomed BV. Check Mainz Biomed's Beneish M Score to see the likelihood of Mainz Biomed's management manipulating its earnings.
Mainz Biomed Workforce Analysis
Traditionally, organizations such as Mainz Biomed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mainz Biomed within its industry.Mainz Biomed Manpower Efficiency
Return on Mainz Biomed Manpower
| Revenue Per Employee | 13.8K | |
| Revenue Per Executive | 74.6K | |
| Net Loss Per Employee | 404.5K | |
| Net Loss Per Executive | 2.2M |
Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.